These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 1684924)

  • 1. Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly. Therapeutic considerations (Part I).
    Greenblatt DJ; Harmatz JS; Shader RI
    Clin Pharmacokinet; 1991 Sep; 21(3):165-77. PubMed ID: 1684924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of age and other drugs on benzodiazepine kinetics.
    Greenblatt DJ; Shader RI
    Arzneimittelforschung; 1980; 30(5a):886-90. PubMed ID: 6106490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacokinetic of benzodiazepines in old age].
    Vozeh S
    Schweiz Med Wochenschr; 1981 Nov; 111(47):1789-93. PubMed ID: 6118950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of benzodiazepine and non-benzodiazepine anxiolytic-hypnotic drugs: an analytical point of view.
    Mandrioli R; Mercolini L; Raggi MA
    Curr Drug Metab; 2010 Nov; 11(9):815-29. PubMed ID: 21189133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and drug interactions of the sedative hypnotics.
    Wang JS; DeVane CL
    Psychopharmacol Bull; 2003; 37(1):10-29. PubMed ID: 14561946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anxiolytics and sedatives and risk of fractures: effects of half-life.
    Vestergaard P; Rejnmark L; Mosekilde L
    Calcif Tissue Int; 2008 Jan; 82(1):34-43. PubMed ID: 18175030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly. Therapeutic considerations (Part II).
    Greenblatt DJ; Harmatz JS; Shader RI
    Clin Pharmacokinet; 1991 Oct; 21(4):262-73. PubMed ID: 1684744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between cerebral pharmacokinetics and anxiolytic activity of diazepam and its active metabolites after a single intra-peritoneal administration of diazepam in mice.
    Dailly E; Hascoët M; Colombel MC; Jolliet P; Bourin M
    Hum Psychopharmacol; 2002 Jul; 17(5):239-45. PubMed ID: 12404681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selectivity in the generalization profile in baboons trained to discriminate lorazepam: benzodiazepines, barbiturates and other sedative/anxiolytics.
    Ator NA; Griffiths RR
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1442-57. PubMed ID: 9316858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacokinetics of the newer benzodiazepines.
    Greenblatt DJ; Divoll M; Abernethy DR; Ochs HR; Shader RI
    Clin Pharmacokinet; 1983; 8(3):233-52. PubMed ID: 6133664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in incident use of benzodiazepines and Z-drugs in France from 2006 to 2012: a population-based study.
    Bénard-Laribière A; Noize P; Pambrun E; Bazin F; Verdoux H; Tournier M; Bégaud B; Pariente A
    Pharmacoepidemiol Drug Saf; 2017 Feb; 26(2):162-169. PubMed ID: 27807907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Problems and pitfalls in the use of benzodiazepines in the elderly.
    Kruse WH
    Drug Saf; 1990; 5(5):328-44. PubMed ID: 2222867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quazepam: hypnotic efficacy and side effects.
    Kales A
    Pharmacotherapy; 1990; 10(1):1-10; discussion 10-2. PubMed ID: 1969151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative pharmacokinetics of 5 hypnotic benzodiazepines in healthy volunteers].
    Jochemsen R; Van Boxtel CJ; Breimer DD
    Nouv Presse Med; 1982 Oct; 11(40):2965-6. PubMed ID: 6128720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of anxiolytics and hypnotics: benzodiazepines, buspirone, zoplicone, and zolpidem.
    Chouinard G; Lefko-Singh K; Teboul E
    Cell Mol Neurobiol; 1999 Aug; 19(4):533-52. PubMed ID: 10379424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benzodiazepines for insomnia in community-dwelling elderly: a review of benefit and risk.
    Grad RM
    J Fam Pract; 1995 Nov; 41(5):473-81. PubMed ID: 7595266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacokinetics of alprazolam. Therapeutic implications.
    Greenblatt DJ; Wright CE
    Clin Pharmacokinet; 1993 Jun; 24(6):453-71. PubMed ID: 8513649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of the newer benzodiazepines.
    Garzone PD; Kroboth PD
    Clin Pharmacokinet; 1989 Jun; 16(6):337-64. PubMed ID: 2567646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Benzodiazepine use in the elderly: the EVA Study].
    Lechevallier N; Fourrier A; Berr C
    Rev Epidemiol Sante Publique; 2003 Jun; 51(3):317-26. PubMed ID: 13130212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and the pharmacodynamic action of midazolam in young and elderly patients undergoing tooth extraction.
    Platten HP; Schweizer E; Dilger K; Mikus G; Klotz U
    Clin Pharmacol Ther; 1998 May; 63(5):552-60. PubMed ID: 9630828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.